Uber reportedly weighed buying Expedia. Analysts have reservations.

Date:

October 17, 2024

Shares of Expedia Group Inc. rallied after the Financial Times on Wednesday reported that ride-hailing giant Uber Technologies Inc. had weighed a possible purchase of the travel-booking platform. But on Thursday, Wall Street analysts were more cautious.

Source link

Feds arrest man who allegedly participated in hack of the SEC’s X account, boosting Bitcoin’s price

Inside Liam Payne’s Friendship With One Direction Bandmate Niall Horan

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Uber reportedly weighed buying Expedia. Analysts have reservations.

Recent posts

Eli Lilly’s Zepbound pricing shuffle leaves some patients fearing higher costs

Consumer sentiment improves for third straight month, as expectations for the economy brighten

Hopes for cooling inflation are stifled by Wall Street’s expectations for Trump 2.0

Biden needs to push through promised student-loan relief before Trump returns to White House, powerful Democrat warns

Cava’s successful steak launch beefs up restaurant chain’s earnings

TSMC, Samsung reportedly consider building huge chip factories in UAE

Lemonade’s stock slides 14% after digital insurer’s soft guidance offsets narrower-than-expected loss

What the presidential election means for gold, oil, natural gas and other commodities

Gold’s record-breaking run comes as stocks hit fresh highs. Is it too late for investors?

Urban Outfitters is departing from its ‘alternative sensibility’ to turn around namesake stores

Home builders, flooring companies and pool maker stocks rally as CPI data boosts rate-cut hopes

Five Below’s stock tumbles on CEO departure and downbeat forecast

Earnings Watch: Walmart reports this week. Its ‘resilience’ will be tested amid signs of consumer slowdown, analyst says

‘DJT’ stock has seen ‘aggressive’ selling by retail investors leading into election

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Related articles

Biden needs to push through promised student-loan relief before Trump returns to White House, powerful Democrat warns

Why natural-gas prices have rallied 18% this week to a one-year high

Here’s Larry Summers’ advice to Trump on the economy and Elon Musk

Trump’s choice of Dr. Oz to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans

Buy gold after its pullbacks — because it may hit $3,000 in 2025

Bitcoin sits near record high. More good news for investors: It’s now less volatile.

RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

Here’s what bond and gold traders are signaling about Russia’s nuclear shift

Company

Follow us